NCT00002212已完成2 期
Phase II Evaluation of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 6
研究概览
简要总结
The purpose of this study is to see if it is safe and effective to give Targretin capsules to patients with AIDS-related Kaposi's sarcoma (KS).
详细描述
This is a multicenter, open-label study to evaluate the safety and efficacy of Targretin capsules in patients with AIDS-related KS. NOTE: The daily dose may be reduced as necessary for toxicity management.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (6)
Loading locations...
相似试验
已完成
3 期
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNon-small Cell Lung CancerNCT00050960Eisai Inc.612
已完成
3 期
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNon-small Cell Lung CancerNCT00050973Eisai Inc.623
暂停
2 期
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)Breast CancerMetastatic Breast CancerNCT06214793Megan Kruse, MD61
已完成
不适用
Special Drug Use Results Survey of Targretin capsules 75-mg in patients with Cutaneous T-cell LymphomasCutaneous T-Cell LymphomasJPRN-UMIN000022568Minophagen Pharmaceutical Co., Ltd.200
招募中
不适用
Special Drug Use-results Survey of Targretin Capsules combined with photo(chemo)therapyCutaneous T-cell lymphomaJPRN-jRCT2031210625pharmacovigilance departmant70